Atlas Trials

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Clinical trial NCT04613895 · UNKNOWN

Trial details

NCT number
NCT04613895
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Erosive Esophagitis
Start date
2020-11-17
Primary completion
2021-05-30
Enrollment
186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.